Marker Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Marker Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Marker Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $232K, a 26.6% decline year-over-year.
  • Marker Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $1.11M, a 2.69% increase from 2021.
  • Marker Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.08M, a 98% increase from 2020.
  • Marker Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $544K, a 142% increase from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.11M +$29K +2.69% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-22
2021 $1.08M +$533K +98% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $544K +$319K +142% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $225K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.